St Vincent's Institute of Medical Research

St Vincent's Institute of Medical Research SVI is an independent medical research institute focussed on improving the health of all Australians

Diseases studied:
- Cancer and its spread
- Heart Disease
- Type 1 diabetes
- Obesity and type 2 diabetes
- Neurodegenerative diseases
- Osteoporosis
- Mental health disorders (metabolism research)
- Infectious diseases
- Rare diseases

Join SVI this for Decoding the future of medical research, a free public event exploring how artificial intelligence i...
06/08/2026

Join SVI this for Decoding the future of medical research, a free public event exploring how artificial intelligence is reshaping the future of healthcare.

Hosted by technology commentator Steve Sammartino, the evening will bring together three leading researchers at the forefront of AI-driven medical innovation, A/Prof Davis McCarthy, A/Prof Elizabeth Paratz and A/Prof Fiona Brownfoot.

Register now: https://events.humanitix.com/svi-presents-decoding-the-future-of-medical-research

Dr Jarmon Lees, Head of SVI’s Cardiometabolic Disease Lab, has been named a recipient of the 2026 Victorian Young Tall P...
04/08/2026

Dr Jarmon Lees, Head of SVI’s Cardiometabolic Disease Lab, has been named a recipient of the 2026 Victorian Young Tall Poppy Science Award.

Presented by the Australian Institute of Policy and Science, the awards recognise outstanding early-career researchers who combine excellence in scientific research with a commitment to engaging the community.

At SVI, Jarmon develops human “mini-hearts” using stem cells to better understand heart disease and accelerate the development of new treatments.

Find out more: https://www.svi.edu.au/news-events/dr-jarmon-lees-honoured-young-tall-poppy-science-award/

SVI researchers have uncovered a previously unknown process that helps cells repair damage in one of the most active and...
23/07/2026

SVI researchers have uncovered a previously unknown process that helps cells repair damage in one of the most active and vulnerable parts of their DNA.

Led by Associate Professor Elaine Sanij and co-authors Dr Ruofei Liu, Dr Jiachen Xuan and Dr Jian Kang, the research shows how a protein called RAD54L helps repair damage in ribosomal RNA genes (rDNA).

Find out more: https://www.svi.edu.au/news-events/svi-researchers-uncover-a-new-dna-protection-process-in-the-nucleolus-that-protects-one-of-the-most-fragile-regions-in-the-genome/

When Oona lines up for the Sydney Marathon this August, every one of the 42 kilometres she runs will be for her nephew N...
17/07/2026

When Oona lines up for the Sydney Marathon this August, every one of the 42 kilometres she runs will be for her nephew Noah and every other child living with Fanconi anaemia.

Oona is aiming to raise $21,000 through the challenge, with funds supporting both Fanconi Anaemia Support Australasia and research at SVI. Her goal is to raise $500 for every kilometre of the gruelling 42 km course, helping fund research that is giving families affected by this rare inherited condition new hope.

Support Oona's fundraiser: https://fasa.org.au/run/

Read more: https://www.svi.edu.au/news-events/running-for-noah-taking-on-the-sydney-marathon-to-support-fanconi-anaemia-research/

As we mark , we're celebrating the next generation of researchers working towards a future free from type 1 diabetes.Dr...
16/07/2026

As we mark , we're celebrating the next generation of researchers working towards a future free from type 1 diabetes.

Dr Kylie Jevon has been awarded the 2026 Helen Thomas Early Career Fellowship in Type 1 Diabetes, recognising the outstanding potential of her research investigating a novel immunotherapy approach and honouring the enduring legacy of Professor Helen Thomas.

Supported by SVI, Diabetes Victoria, the Australian Diabetes Society and Breakthrough T1D Australia, and the fellowship will support Kylie's project exploring how T cell exhaustion could be harnessed to treat type 1 diabetes, helping lay the groundwork for new treatments that target the underlying immune cause of the disease.

Find out more: https://www.svi.edu.au/news-events/a-legacy-that-lives-on-through-the-next-generation-of-discovery/

This National Diabetes Week, we're celebrating research that's helping create a future where type 1 diabetes could one d...
13/07/2026

This National Diabetes Week, we're celebrating research that's helping create a future where type 1 diabetes could one day be prevented before it starts.

Associate Professor Mark Chong has been awarded a Breakthrough T1D INSPIRE grant to advance the development of an innovative mRNA vaccine designed to retrain the immune system to stop attacking the body's own insulin-producing cells.

While there's still more work ahead, this research represents an exciting step towards changing the future of type 1 diabetes.

Find out more: https://www.svi.edu.au/news-events/new-grant-to-advance-mrna-vaccine-for-type-1-diabetes/

Breakthrough T1D Australia | Breakthrough T1D

The BRAIx randomised controlled trials are now underway, marking a major milestone in the development of AI-powered brea...
08/07/2026

The BRAIx randomised controlled trials are now underway, marking a major milestone in the development of AI-powered breast cancer screening.

Led by Associate Professor Helen Frazer and Associate Professor Davis McCarthy, the BRAIx project brings together clinical expertise and cutting-edge artificial intelligence to improve breast cancer detection.

More than 45,000 BreastScreen Victoria clients have now participated in the randomised controlled trial, with over 21,000 mammograms assessed using the BRAIx AI reader.

The study is now expanding to BreastScreen SA in South Australia, marking another important milestone as the technology is evaluated across different settings.

The Australian-developed BRAIx AI reader was created through a partnership between SVI, St Vincent's Hospital Melbourne, BreastScreen Victoria, the University of Melbourne and the University of Adelaide, with funding from the Medical Research Future Fund and philanthropic support from MECCA Brands M-POWER.

Each year in Australia, about 1,000 Australian women lose their lives to ovarian cancer. While advances in treatment hav...
08/07/2026

Each year in Australia, about 1,000 Australian women lose their lives to ovarian cancer. While advances in treatment have improved outcomes for many patients, ovarian cancers can eventually stop responding to therapies, leaving women with limited options.

Thanks to the generosity of the 5point Foundation, SVI researcher Dr Ruofei Liu will continue searching for new solutions as the 2026 recipient of the Christine Martin Fellowship.

Find out more: https://www.svi.edu.au/news-events/fellowship-fuels-search-for-new-ovarian-cancer-treatments/

Associate Professor Elizabeth Paratz, Team Leader of SVI’s Heart Exercise & Research Trials (HEART) Lab and cardiologist...
06/07/2026

Associate Professor Elizabeth Paratz, Team Leader of SVI’s Heart Exercise & Research Trials (HEART) Lab and cardiologist at St Vincent's Hospital Melbourne, has led a new publication highlighting a landmark achievement for cardiovascular care in Timor-Leste: the establishment of the country’s first Cardiac Society.

Find out more: https://www.svi.edu.au/news-events/helping-strengthen-cardiac-care-in-timor-leste/

Address

9 Princes Street
Melbourne, VIC
3065

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61392312391

Website

Alerts

Be the first to know and let us send you an email when St Vincent's Institute of Medical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to St Vincent's Institute of Medical Research:

Shortcuts

Featured

Share